Oral targeted therapy dose adaptation in older patients with cancer: A real‐life French cohort-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Oral targeted therapy dose adaptation in older patients with cancer: A real‐life French cohort

Published:2022-03-15 Issue:7 Volume:88 Page:3370-3377
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Brit J Clinical Pharma

Author:

Carbasse Clément¹^ORCID,Leenhardt Fanny¹²³^ORCID,Jacot William³⁴⁵^ORCID,Perrier Caroline¹,Pinguet Frederic¹,Viala Marie⁴

Affiliation:

1. Department of Pharmacy Institut du Cancer de Montpellier Montpellier France

2. Pharmacokinetic Laboratory University of Montpellier Montpellier France

3. INSERM U1194 IRCM Montpellier France

4. Department of Medical Oncology Institut du Cancer de Montpellier Montpellier France

5. University of Montpellier Montpellier France

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.15285

Reference43 articles.

1. Comparison of FDA Approved Kinase Targets to Clinical Trial Ones: Insights from Their System Profiles and Drug-Target Interaction Networks

2. Hallmarks of Cancer: The Next Generation

3. Oral single-agent chemotherapy in older patients with solid tumours: A position paper from the International Society of Geriatric Oncology (SIOG)

4. Patient and provider perspectives on delivery of oral cancer therapies

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP